S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 02:28 AM ET

NVOS

Novo Integrated Sciences, Inc.

Price Chart
Latest Quote

$0.00

+0.00 (+0.00%)
Current Price
Previous Close $0.00
Open $0.01
Day High $0.01
Day Low $0.01
Volume 1,507
Fetched: 2026-06-21T06:28:08
Stock Information
Shares Outstanding 19.73M
Total Debt $5.98M
Cash Equivalents $845K
Revenue $13.29M
Net Income $-16.17M
Sector Healthcare
Industry Medical Care Facilities
Market Cap $14K
EPS (TTM) $-1.33
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$4.87M
Sales$13.29M
Income$-16.17M
Book/sh$0.78
Cash/sh$0.04
Employees115
Financial Ratios
Quick Ratio0.19
Current Ratio0.37
Debt/Eq40.92
Returns & Margins
ROA-15.35%
ROE-82.47%
Gross Margin43.20%
Operating Margin-30.39%
Profit Margin-121.61%
Ownership
Insider Ownership6.59%
Insider & Institutional transactions data not available
Valuation Ratios
P/S0.00
P/B0.00
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.01
SMA50$0.01
SMA200$0.00
RSI7.11
ATR0.0026
Shares Float18.43M
Short Float1.45%
Short Ratio1.13
Volatility5.99
Rel Volume0.23
Performance History
Week-92.22%
Month-77.42%
Quarter+16.67%
6 Months-66.67%
YTD-74.07%
Year-44.00%
3 Years-99.95%
5 Years-100.00%
10 Years-100.00%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-19 $0.00 1,507
2026-06-18 $0.00 0
2026-06-17 $0.00 26,025
2026-06-16 $0.00 5,006
2026-06-15 $0.00 51,180
2026-06-12 $0.01 0
2026-06-11 $0.01 0
2026-06-10 $0.01 0
2026-06-09 $0.01 0
2026-06-08 $0.01 0
2026-06-05 $0.01 10,906
2026-06-04 $0.02 0
2026-06-03 $0.02 0
2026-06-02 $0.02 0
2026-06-01 $0.02 22,131
2026-05-29 $0.02 0
2026-05-28 $0.02 4,016
2026-05-27 $0.02 5,025
2026-05-26 $0.00 4,370
2026-05-22 $0.00 3,176
2026-05-21 $0.00 254
2026-05-20 $0.00 1,714
2026-05-19 $0.00 19,220
About Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.

📰 Latest News
No news articles available at the moment. Check back later for updates on NVOS.
Period:
Loading...
Income Statement (Annual)
Metric 2023-08-31 2022-08-31 2021-08-31
Revenue
Reconciled Cost Of Revenue $7,619,304 $6,938,699 $5,482,257
Cost Of Revenue $7,619,304 $6,938,699 $5,482,257
Total Revenue $12,572,019 $11,737,937 $9,305,255
Operating Revenue $12,572,019 $11,737,937 $9,305,255
Expenses
Interest Expense $5,117,692 $7,568,248 $165,003
Total Expenses $21,125,181 $21,324,040 $13,579,423
Other Income Expense $392,383 $-16,082,217 $-77,451
Other Non Operating Income Expenses $607,589 - $21,900
Net Non Operating Interest Income Expense $-5,108,665 $-7,399,160 $-119,316
Interest Expense Non Operating $5,117,692 $7,568,248 $165,003
Operating Expense $13,505,877 $14,385,341 $8,097,166
Selling And Marketing Expense $15,149 $20,702 $7,525
General And Administrative Expense $13,490,728 $14,364,639 $8,089,641
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-13,214,552 $-32,849,215 $-4,462,147
Net Interest Income $-5,108,665 $-7,399,160 $-119,316
Interest Income $9,027 $169,088 $45,687
Normalized Income $-12,999,346 $-16,766,998 $-4,362,796
Net Income From Continuing And Discontinued Operation $-13,214,552 $-32,849,215 $-4,462,147
Total Operating Income As Reported $-8,553,162 $-25,026,677 $-4,373,519
Net Income Common Stockholders $-13,214,552 $-32,849,215 $-4,462,147
Net Income $-13,214,552 $-32,849,215 $-4,462,147
Net Income Including Noncontrolling Interests $-13,269,444 $-33,045,178 $-4,470,935
Net Income Continuous Operations $-13,269,444 $-33,045,178 $-4,470,935
Pretax Income $-13,269,444 $-33,067,480 $-4,470,935
Special Income Charges $0 $-15,440,574 $-99,351
Interest Income Non Operating $9,027 $169,088 $45,687
Operating Income $-8,553,162 $-9,586,103 $-4,274,168
Gross Profit $4,952,715 $4,799,238 $3,822,998
Per Share
Diluted EPS $-1.30 $-11.30 $-1.80
Basic EPS $-1.30 $-11.30 $-1.80
Other
Tax Effect Of Unusual Items $0 $0 $0
Tax Rate For Calcs $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-5,633,792 $-6,397,762 $-2,482,459
Total Unusual Items $-215,206 $-16,082,217 $-99,351
Total Unusual Items Excluding Goodwill $-215,206 $-16,082,217 $-99,351
Reconciled Depreciation $2,302,754 $3,019,253 $1,724,122
EBITDA (Bullshit earnings) $-5,848,998 $-22,479,979 $-2,581,810
EBIT $-8,151,752 $-25,499,232 $-4,305,932
Diluted Average Shares $10,165,548 $2,912,262 $2,477,445
Basic Average Shares $10,165,548 $2,912,262 $2,477,445
Diluted NI Availto Com Stockholders $-13,214,552 $-32,849,215 $-4,462,147
Minority Interests $54,892 $195,963 $8,788
Tax Provision $0 $-22,302 $0
Write Off $0 $14,083,531 $99,351
Impairment Of Capital Assets $0 $1,357,043 $99,351
Gain On Sale Of Security $-215,206 $-641,643 -
Selling General And Administration $13,505,877 $14,385,341 $8,097,166
Other Gand A $13,490,728 $14,364,639 $8,089,641
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2023-08-31 2022-08-31 2021-08-31
Assets
Net Tangible Assets $1,014,923 $-4,361,304 $2,346,069
Total Assets $35,563,047 $40,872,840 $61,958,281
Total Non Current Assets $31,174,958 $35,141,045 $50,824,772
Goodwill And Other Intangible Assets $23,801,022 $26,666,463 $41,518,347
Other Intangible Assets $16,218,539 $18,840,619 $32,029,499
Current Assets $4,388,089 $5,731,795 $11,133,509
Other Current Assets $346,171 $571,335 $218,376
Prepaid Assets $1,051,584 $1,085,335 $218,376
Inventory $1,106,983 $879,033 $339,385
Receivables $1,467,028 $1,017,405 $2,282,586
Receivables Adjustments Allowances $-864,215 $-992,329 $-1,097,628
Other Receivables $108,000 $180,259 $968,715
Accounts Receivable $2,223,243 $1,829,475 $2,411,499
Cash Cash Equivalents And Short Term Investments $416,323 $2,178,687 $8,293,162
Cash And Cash Equivalents $416,323 $2,178,687 $8,293,162
Non Current Accounts Receivable - - $692,738
Debt
Net Debt $1,934,613 $8,028,677 $2,787,216
Total Debt $4,471,649 $12,995,747 $13,708,381
Long Term Debt And Capital Lease Obligation $1,758,615 $3,305,115 $8,189,831
Long Term Debt $65,038 $1,107,710 $6,115,809
Current Debt And Capital Lease Obligation $2,713,034 $9,690,632 $5,518,550
Current Debt $2,285,898 $9,099,654 $4,964,569
Other Current Borrowings $2,285,898 $9,099,654 $4,964,569
Liabilities
Total Liabilities Net Minority Interest $11,063,972 $18,825,269 $18,154,126
Total Non Current Liabilities Net Minority Interest $3,159,114 $4,750,563 $9,690,203
Non Current Deferred Liabilities $1,400,499 $1,445,448 $1,500,372
Non Current Deferred Taxes Liabilities $1,400,499 $1,445,448 $1,500,372
Current Liabilities $7,904,858 $14,074,706 $8,463,923
Other Current Liabilities $61,767 $534,595 -
Current Deferred Liabilities $35,434 $36,887 $38,631
Payables And Accrued Expenses $5,094,623 $3,812,592 $2,906,742
Interest Payable $382,666 $454,189 $366,280
Payables $3,513,842 $2,279,165 $1,449,784
Accounts Payable $3,513,842 $1,800,268 $1,449,784
Equity
Common Stock Equity $24,815,945 $22,305,159 $43,864,416
Total Equity Gross Minority Interest $24,499,075 $22,047,571 $43,804,155
Stockholders Equity $24,815,945 $22,305,159 $43,864,416
Other Equity Interest $1,217,293 $9,474,807 $9,236,607
Gains Losses Not Affecting Retained Earnings $-357,383 $560,836 $991,077
Other Equity Adjustments $-357,383 $560,836 $991,077
Retained Earnings $-67,033,041 $-53,818,489 $-20,969,274
Other
Treasury Shares Number $0 - -
Ordinary Shares Number $16,811,879 $3,118,060 $2,661,014
Share Issued $16,811,879 $3,118,060 $2,661,014
Tangible Book Value $1,014,923 $-4,361,304 $2,346,069
Invested Capital $27,166,881 $32,512,523 $54,944,794
Working Capital $-3,516,769 $-8,342,911 $2,669,586
Capital Lease Obligations $2,120,713 $2,788,383 $2,628,003
Total Capitalization $24,880,983 $23,412,869 $49,980,225
Minority Interest $-316,870 $-257,588 $-60,261
Additional Paid In Capital $90,973,316 $66,084,887 $54,579,396
Capital Stock $15,760 $3,118 $26,610
Common Stock $15,760 $3,118 $26,610
Preferred Stock $0 $0 $0
Long Term Capital Lease Obligation $1,693,577 $2,197,405 $2,074,022
Current Deferred Revenue $35,434 $36,887 $38,631
Current Capital Lease Obligation $427,136 $590,978 $553,981
Current Accrued Expenses $1,580,781 $1,533,427 $1,456,958
Goodwill $7,582,483 $7,825,844 $9,488,848
Net PPE $7,373,936 $8,474,582 $8,613,687
Accumulated Depreciation $-1,253,209 $-1,004,732 $-646,442
Gross PPE $8,627,145 $9,479,314 $9,260,129
Leases $841,371 $868,375 $691,318
Other Properties $3,900,579 $4,601,573 $4,418,933
Machinery Furniture Equipment $116,295 $119,503 $112,208
Buildings And Improvements $3,325,500 $3,432,232 $3,562,650
Land And Improvements $443,400 $457,631 $475,020
Properties $0 $0 $0
Inventories Adjustments Allowances $0 $-1,027,670 $-1,066,721
Finished Goods $636,896 $507,416 $243,912
Work In Process $81,696 $139,333 $144,628
Raw Materials $388,391 $1,259,954 $1,017,566
Dueto Related Parties Current - $478,897 -
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2023-08-31 2022-08-31 2021-08-31
Free Cash Flow
Free Cash Flow $-2,292,539 $-6,074,313 $-1,280,751
Operating Activities
Operating Cash Flow $-2,243,315 $-5,884,145 $-1,024,802
Cash Flow From Continuing Operating Activities $-2,243,310 $-5,884,145 $-1,024,802
Operating Gains Losses $215,206 $641,643 $133,596
Investing Activities
Capital Expenditure $-49,224 $-190,168 $-255,949
Investing Cash Flow $-49,224 $163,459 $2,999,122
Cash Flow From Continuing Investing Activities $-49,224 $163,459 $2,999,122
Net Other Investing Changes - $296,138 $-473,100
Financing Activities
Issuance Of Capital Stock $1,795,000 $0 $7,327,580
Financing Cash Flow $763,860 $-427,117 $4,316,862
Cash Flow From Continuing Financing Activities $763,860 $-427,117 $4,316,862
Net Other Financing Charges $7,206 $16,600 $-246,327
Net Common Stock Issuance $1,795,000 $0 $7,327,580
Common Stock Issuance $1,795,000 $0 $7,327,580
Other
Repayment Of Debt $-3,079,629 $-15,713,717 $-2,776,391
Issuance Of Debt $1,285,903 $15,270,000 $0
Interest Paid Supplemental Data $432,094 $1,502,819 $144,987
Income Tax Paid Supplemental Data $0 $0 $0
End Cash Position $416,323 $2,178,687 $8,293,162
Beginning Cash Position $2,178,687 $8,293,162 $2,067,718
Effect Of Exchange Rate Changes $-233,685 $33,328 $-65,738
Changes In Cash $-1,528,679 $-6,147,803 $6,291,182
Proceeds From Stock Option Exercised $532,600 $0 $12,000
Net Issuance Payments Of Debt $-1,570,946 $-443,717 $-2,776,391
Net Short Term Debt Issuance $-1,747,985 $10,165,833 $0
Short Term Debt Payments $-3,033,888 $-5,104,167 $0
Short Term Debt Issuance $1,285,903 $15,270,000 $0
Net Long Term Debt Issuance $177,039 $-10,609,550 $-2,776,391
Long Term Debt Payments $-45,741 $-10,609,550 $-2,776,391
Net Business Purchase And Sale $0 $57,489 $3,728,171
Sale Of Business $0 $57,489 $3,738,171
Net PPE Purchase And Sale $-49,224 $-190,168 $-255,949
Purchase Of PPE $-49,224 $-190,168 $-255,949
Change In Working Capital $460,679 $-823,102 $-29,100
Change In Other Current Liabilities $-762,852 $-806,394 $-618,645
Change In Payables And Accrued Expense $1,866,121 $423,330 $-323,247
Change In Accrued Expense $95,532 $140,096 $-278,019
Change In Interest Payable $-58,066 $101,353 $9,015
Change In Payable $1,770,589 $283,234 $-45,228
Change In Account Payable $1,770,589 $283,234 $-45,228
Change In Prepaid Assets $210,382 $-369,647 $-43,194
Change In Inventory $-255,781 $-527,397 $-147,814
Change In Receivables $-597,191 $457,006 $1,103,800
Changes In Account Receivables $-597,191 $457,006 $1,103,800
Other Non Cash Items $7,662,155 $8,156,303 $1,518,164
Stock Based Compensation $385,335 $426,690 $155,496
Asset Impairment Charge $0 $15,740,246 $99,351
Depreciation Amortization Depletion $2,302,754 $3,019,253 $1,724,122
Depreciation And Amortization $2,302,754 $3,019,253 $1,724,122
Net Foreign Currency Exchange Gain Loss $215,206 $641,643 $0
Net Income From Continuing Operations $-13,269,444 $-33,045,178 $-4,470,935
Purchase Of Business - $0 $-10,000
Gain Loss On Investment Securities - $426,690 $155,496
Fetched: 2026-02-02